During the past decade, Mercy Clinic-Rolla-Cancer and Hematology conducted 159 clinical trials. In the 10-year time frame, 159 clinical trials started and 74 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 56 clinical trials were completed. i.e. 73.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Clinic-Rolla-Cancer and Hematology" #1 sponsor was "National Cancer Institute (NCI)" with 107 trials, followed by "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "SWOG Cancer Research Network" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "Gynecologic Oncology Group" with 22 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic-Rolla-Cancer and Hematology" #1 collaborator was "National Cancer Institute (NCI)" with 107 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Clinic-Rolla-Cancer and Hematology" are "Invasive Breast Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Metastatic Malignant Neoplasm in the Brain" (7 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (7 trials). Many other conditions were trialed in "Mercy Clinic-Rolla-Cancer and Hematology" in a lesser frequency.

Most popular intervention types in "Mercy Clinic-Rolla-Cancer and Hematology" are "Drug" (166 trials), "Other" (132 trials), "Biological" (94 trials), "Procedure" (62 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Quality-of-Life Assessment" (51 trials), "Questionnaire Administration" (35 trials), "Biospecimen Collection" (31 trials) and "Computed Tomography" (29 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Clinic-Rolla-Cancer and Hematology" are 173 trials for "All" genders, 40 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Clinic-Rolla-Cancer and Hematology". undefined are not yet recruiting, 71 are recruiting, 99 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Mercy Clinic-Rolla-Cancer and Hematology, 8 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Clinic-Rolla-Cancer and Hematology, 6 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".